Balanced news tone
News Sentiment
DERM sentiment intelligence
Journey Medical Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
42 relevant articles
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-2.5% over one week, +9.0% over four weeks, trend inactive, and near fair-value range.
Journey Medical (DERM) gains 13.3% shareholder in Wasatch Advisors
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
78/100 classification
One-week reaction
-2.5%
Price reacting lower
Trend fit
Trend inactive
9.0% over four weeks
Fair value
24.0%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
33
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Benzinga
Direct company coverage
Transcript: Journey Medical Q1 2026 Earnings Conference Call
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 21:17
- Source
- Benzinga
Market source
Direct company coverage
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q1 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Market source
The Motley Fool
Direct company coverage
Journey Medical (DERM) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- The Motley Fool
Market source
Direct company coverage
Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- GlobeNewswire
Market source
Direct company coverage
Why The Journey Medical (DERM) Narrative Is Shifting With New Targets And Going Concern Risks
- Tone
- Negative 18/100
- Event
- Balance sheet
- Published
- 29 Mar 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Journey Medical (DERM) Losses Narrow In Q4 EPS Result Tests Bullish Profitability Narrative
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Mar 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Mar 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Journey Medical Corp (DERM) Q4 2025: Everything You Need To Know Ahead Of Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Mar 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Dermatology drug seller Journey Medical to detail 2025 results on Mar. 25
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Mar 2026 07:00
- Source
- Stock Titan
TradingView
Direct company coverage
DERM Stock Price and Chart — NASDAQ:DERM
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2017 02:22
- Source
- TradingView
MarketBeat
Direct company coverage
Journey Medical (DERM) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Aug 2016 16:20
- Source
- MarketBeat